Goldman Sachs’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.05M Sell
1,361,957
-181,293
-12% -$1.13M ﹤0.01% 3363
2025
Q4
$11.3M Buy
1,543,250
+557,080
+56% +$5.4M ﹤0.01% 2983
2025
Q3
$9.83M Buy
986,170
+623,035
+172% +$6.9M ﹤0.01% 2985
2025
Q2
$3.29M Sell
363,135
-937,182
-72% -$6.11M ﹤0.01% 3804
2025
Q1
$8.35M Sell
1,300,317
-1,180,532
-48% -$10.5M ﹤0.01% 2865
2024
Q4
$23.6M Sell
2,480,849
-111,226
-4% -$976K ﹤0.01% 1961
2024
Q3
$21.2M Buy
2,592,075
+975,075
+60% +$10.1M ﹤0.01% 2018
2024
Q2
$21.9M Buy
1,617,000
+249,343
+18% +$2.09M ﹤0.01% 1820
2024
Q1
$9.59M Sell
1,367,657
-263,234
-16% -$2.29M ﹤0.01% 2489
2023
Q4
$17.9M Buy
1,630,891
+445,925
+38% +$4.38M ﹤0.01% 2007
2023
Q3
$13M Sell
1,184,966
-2,272,347
-66% -$32.5M ﹤0.01% 2172
2023
Q2
$54.6M Buy
3,457,313
+3,215,330
+1,329% +$37.4M 0.01% 1040
2023
Q1
$3.16M Sell
241,983
-57,010
-19% -$468K ﹤0.01% 3481
2022
Q4
$3.25M Sell
298,993
-893,287
-75% -$11M ﹤0.01% 3541
2022
Q3
$19.1M Buy
1,192,280
+972,266
+442% +$14.4M ﹤0.01% 1912
2022
Q2
$1.72M Sell
220,014
-22,495
-9% -$212K ﹤0.01% 4172
2022
Q1
$3.03M Buy
242,509
+32,312
+15% +$453K ﹤0.01% 3849
2021
Q4
$5.02M Sell
210,197
-818,675
-80% -$19.8M ﹤0.01% 3403
2021
Q3
$17M Sell
1,028,872
-633,005
-38% -$9.53M ﹤0.01% 2225
2021
Q2
$33.4M Buy
1,661,877
+709,701
+75% +$9.63M 0.01% 1615
2021
Q1
$11.1M Buy
+952,176
New +$12.5M ﹤0.01% 2472

Other funds holding ENVX

Goldman Sachs's ENVX Position: Q1 2026 in Review

Goldman Sachs reduced its Enovix (ENVX) stake by 12% in Q1 2026, selling an estimated $1.13M and leaving 1,361,957 shares worth $7.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3363.

Goldman Sachs first reported a position in ENVX in Q1 2021 and has held it in 21 quarters since. The position peaked at $54.6M in Q2 2023. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Goldman Sachs held 1,361,957 shares of Enovix worth $7.05M as of Q1 2026.
  • Goldman Sachs sold 181,293 Enovix shares in Q1 2026, an estimated $1.13M.
  • Enovix made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3363 holding.
  • Goldman Sachs first reported a position in Enovix in Q1 2021 and has held it in 21 quarters since.
  • Goldman Sachs's Enovix position peaked at $54.6M in Q2 2023.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.